The PBS ensures that our tax dollars are spent efficiently by comparing the need, price and efficacy of medicines. American pharmaceutical companies see this as a barrier to free trade, a barrier to greater profits. If Australia scrapped its PBS the way the American pharmaceutical companies want us to, then we will all be paying more for our medicines. These same trade negotiations will see the life of pharmaceutical patents extend well beyond 20 years. This will mean that cheaper generic versions of a new drug can’t be made. People who rely on generic medicines will have to wait longer for cheaper life saving drugs. For people in developing countries, that’s a death sentence. It’s also a major concern for Australian pensioners and anyone else who relies on cheaper medicines.